Skip to main content

Tango Therapeutics, Inc.

TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819133

In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Tango Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
2 insiders, $2.34M in total
Insiders trading
2
Net value
−$2.34M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Tango Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Tango Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Newcomb JessicaPrincipal Accounting Officer59,121Sep 24, 20261
Crystal AdamPresident, R&D115,743Sep 3, 202611
Azelby RobertDirector5,740Jun 23, 20261
Calhoun Lesley AnnDirector16,500Jun 8, 20261
Lee SungDirector22,870Jun 8, 20263
Rothenberg MaceDirector41,500Jun 8, 20261
Ketchum John BDirector24,937Jun 8, 20261
Gall MatthewChief Financial Officer40,000May 5, 20261
Beckman DaniellaChief Financial Officer184,297Feb 4, 20261
Weber BarbaraDirector, Executive Chair1,629,254Feb 4, 20261
Peters MaltePresident & CEO367,500Jan 12, 20262
TRV GP IV, LLC10% Owner13,386,574Oct 27, 20252
Third Rock Ventures GP IV, L.P.10% Owner13,386,574Oct 27, 20252
Third Rock Ventures IV, L.P.10% Owner13,386,574Oct 27, 20252
Borisy AlexisDirector17,500Jun 9, 20250
Barry DouglasGeneral Counsel66,014Feb 6, 20250
EcoR1 Capital, LLC10% Owner10,630,736IndirectNov 8, 20240
Davis Aaron I.Other: See remarks3,610,642IndirectNov 7, 20240
Boxer Capital Management, LLCOther: See remarks3,610,642IndirectNov 7, 20240
MVA Investors, LLCOther: See remarks108,793Jul 2, 20240
Lewis JosephOther: See remarks8,198,642Oct 17, 20230
Boxer Asset Management Inc.Other: See remarks8,198,642Oct 17, 20230
Boxer Capital, LLCOther: See remarks8,198,642Oct 17, 20230
Huber Reid MDirector5,000Jun 8, 20230
Huang AlanChief Scientific Officer167,584Mar 2, 20230
Weitzman AaronChief Medical Officer–Dec 5, 20220
Rudoltz MarcChief Medical Officer–Nov 3, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 24, 2026 (view filing)7:41 PM ETSep 222 daysNewcomb JessicaPrincipal Accounting OfficerSSale−8.20K$24.22−$198.6K−12.2%59.1K after3 lots10b5-1
Sep 3, 2026 (view filing)4:01 PM ETSep 12 daysCrystal AdamPresident, R&DSSale−27.0K$22.37−$603.9K−18.9%115.7K after10b5-1
Aug 5, 2026 (view filing)4:01 PM ETAug 32 daysCrystal AdamPresident, R&DSSale−27.0K$27.24−$735.5K−18.9%115.7K after2 lots10b5-1
Jul 2, 2026 (view filing)7:23 PM ETJul 11 dayCrystal AdamPresident, R&DSSale−27.0K$29.59−$798.9K−18.9%115.7K after2 lots10b5-1
Jun 3, 2026 (view filing)Jun 12 daysCrystal AdamPresident, R&DSSale−27.0K$22.88−$617.6K−18.9%115.7K after2 lots10b5-1
May 5, 2026 (view filing)May 14 daysCrystal AdamPresident, R&DSSale−27.0K$21.22−$573.0K−18.9%115.7K after2 lots10b5-1
Apr 16, 2026 (view filing)Apr 151 dayCrystal AdamPresident, R&DSSale−38.5K$25.00−$961.5K−25.5%112.6K after10b5-1
Apr 2, 2026 (view filing)Apr 11 dayCrystal AdamPresident, R&DSSale−27.0K$21.20−$572.4K−19.3%112.6K after10b5-1
Mar 27, 2026 (view filing)Mar 252 daysCrystal AdamPresident, R&DSSale−12.0K$20.11−$241.3K−9.6%112.6K after10b5-1
Mar 9, 2026 (view filing)Mar 54 daysCrystal AdamPresident, R&DSSale−20.3K$15.00−$303.8K−15.2%112.6K after10b5-1
Feb 27, 2026 (view filing)Feb 252 daysCrystal AdamPresident, R&DSSale−54.3K$12.77−$694.0K−29.0%132.9K after10b5-1
Feb 4, 2026 (view filing)Feb 31 dayBeckman DaniellaChief Financial OfficerSSale−10.3K$12.27−$126.6K−5.3%184.3K after2 lots
Feb 4, 2026 (view filing)Feb 31 dayWeber BarbaraDirector, Executive ChairSSale−30.5K$12.27−$374.4K−1.8%1.63M after2 lots
Feb 4, 2026 (view filing)Feb 31 dayCrystal AdamPresident, R&DSSale−18.5K$12.27−$226.4K−9.0%187.2K after2 lots
Oct 27, 2025 (view filing)4:15 PM ETOct 234 daysTRV GP IV, LLC and 2 others10% OwnerSSale−477.4K$10.15−$4.85M−3.4%13.4M after
Sep 29, 2025 (view filing)4:15 PM ETSep 254 daysTRV GP IV, LLC and 2 others10% OwnerSSale−500.0K$8.02−$4.01M−3.5%13.9M after
Sep 17, 2025 (view filing)6:06 PM ETSep 161 dayTRV GP IV, LLC and 2 others10% OwnerSSale−363.5K$7.04−$2.56M−2.5%14.4M after
Sep 9, 2025 (view filing)4:15 PM ETSep 5-84 daysTRV GP IV, LLC and 2 others10% OwnerSSale−729.4K$7.00−$5.11M−4.7%14.7M after2 lots
Aug 26, 2025 (view filing)4:15 PM ETAug 224 daysTRV GP IV, LLC and 2 others10% OwnerSSale−302.2K$7.00−$2.12M−1.9%15.5M after
Aug 21, 2025 (view filing)4:15 PM ETAug 192 daysTRV GP IV, LLC and 2 others10% OwnerSSale−1.10M$7.01−$7.71M−6.5%15.8M after
Feb 6, 2025 (view filing)Feb 4-52 daysBarry DouglasGeneral CounselSSale−5.33K$3.07−$16.4K−7.5%66.0K after2 lots
Feb 6, 2025 (view filing)Feb 4-52 daysBeckman DaniellaChief Financial OfficerSSale−8.23K$3.07−$25.3K−5.2%150.3K after2 lots
Feb 6, 2025 (view filing)Feb 4-52 daysCrystal AdamSee RemarksSSale−14.3K$3.07−$43.9K−8.3%158.2K after2 lots
Feb 6, 2025 (view filing)Feb 4-52 daysWeber BarbaraChief Executive OfficerSSale−18.8K$3.07−$57.7K−1.1%1.62M after2 lots
Nov 18, 2024 (view filing)Nov 14-184 daysRothenberg MaceDirectorPPurchase+20.0K$3.70+$74.0K+177.8%31.3K after2 lots
Nov 8, 2024 (view filing)Nov 6-72 daysEcoR1 Capital, LLC10% OwnerSSale−2.70M$3.13−$8.45M−20.3%10.6M after3 lots
Nov 7, 2024 (view filing)9:30 PM ETNov 61 dayDavis Aaron I. and 1 otherOther: See remarksSSale−3.08M$3.14−$9.67M−46.0%3.61M after
Oct 28, 2024 (view filing)6:59 AM ETOct 253 daysDavis Aaron I. and 1 otherOther: See remarks.SSale−633.0K$6.87−$4.35M−8.6%6.69M after
Oct 23, 2024 (view filing)9:31 PM ETOct 21-222 daysDavis Aaron I. and 1 otherOther: See remarksSSale−875.0K$6.97−$6.10M−10.7%7.32M after2 lots
Sep 17, 2024 (view filing)4:48 PM ETSep 134 daysTRV GP IV, LLC and 2 others10% OwnerSSale−67.4K$10.53−$709.8K−0.4%16.9M after
Sep 9, 2024 (view filing)7:19 PM ETSep 54 daysTRV GP IV, LLC and 2 others10% OwnerSSale−75.0K$11.56−$867.1K−0.4%16.9M after
Sep 4, 2024 (view filing)8:42 PM ETAug 305 daysTRV GP IV, LLC and 2 others10% OwnerSSale−175.0K$11.60−$2.03M−1.0%17.0M after
Aug 29, 2024 (view filing)4:40 PM ETAug 272 daysTRV GP IV, LLC and 2 others10% OwnerSSale−25.0K$11.55−$288.7K−0.1%17.2M after
Aug 20, 2024 (view filing)5:59 PM ETAug 16-194 daysTRV GP IV, LLC and 2 others10% OwnerSSale−285.0K$9.95−$2.84M−1.6%17.2M after2 lots
Aug 1, 2024 (view filing)5:51 PM ETJul 30-Aug 12 daysTRV GP IV, LLC and 2 others10% OwnerSSale−235.0K$9.86−$2.32M−1.3%17.5M after3 lots
Jul 30, 2024 (view filing)4:15 PM ETJul 264 daysTRV GP IV, LLC and 2 others10% OwnerSSale−50.0K$9.84−$491.9K−0.3%17.7M after
Jul 26, 2024 (view filing)4:15 PM ETJul 24-252 daysTRV GP IV, LLC and 2 others10% OwnerSSale−300.6K$9.83−$2.96M−1.7%17.8M after2 lots
Jul 24, 2024 (view filing)4:15 PM ETJul 22-232 daysTRV GP IV, LLC and 2 others10% OwnerSSale−387.7K$9.78−$3.79M−2.1%18.1M after2 lots
Jul 22, 2024 (view filing)4:15 PM ETJul 184 daysTRV GP IV, LLC and 2 others10% OwnerSSale−191.5K$9.81−$1.88M−1.0%18.5M after
Jul 18, 2024 (view filing)4:15 PM ETJul 171 dayTRV GP IV, LLC and 2 others10% OwnerSSale−550.2K$9.79−$5.39M−2.9%18.7M after
Jul 2, 2024 (view filing)8:56 PM ETJun 28-Jul 24 daysDavis Aaron I. and 1 otherOther: See remarksSSale−234.7K$8.76−$2.06M−68.3%108.8K after3 lots
Jun 7, 2024 (view filing)9:14 PM ETJun 6-71 dayDavis Aaron I. and 1 otherOther: See remarksSSale−140.0K$7.04−$985.9K−29.0%343.5K after2 lots
Jun 7, 2024 (view filing)Jun 52 daysCalhoun Lesley AnnDirectorSSale+5.00K$7.21+$36.0K+400.0%6.25K after10b5-1
May 3, 2024 (view filing)9:34 PM ETMay 1-32 daysDavis Aaron I. and 1 otherOther: See remarksSSale−210.0K$7.53−$1.58M−30.3%483.5K after3 lots
Feb 21, 2024 (view filing)5:52 PM ETFeb 201 dayTRV GP IV, LLC and 2 others10% OwnerSSale−162.5K$12.00−$1.95M−0.8%19.2M after
Feb 8, 2024 (view filing)Feb 6-72 daysWeber BarbaraChief Executive OfficerSSale−9.14K$12.59−$115.0K−0.6%1.54M after2 lots
Feb 8, 2024 (view filing)Feb 6-72 daysBarry DouglasGeneral CounselSSale−2.78K$12.59−$34.9K−5.9%44.0K after2 lots
Feb 8, 2024 (view filing)Feb 6-72 daysBeckman DaniellaChief Financial OfficerSSale−3.73K$12.59−$46.9K−2.7%132.4K after2 lots
Feb 8, 2024 (view filing)Feb 6-72 daysCrystal AdamSee RemarksSSale−8.37K$12.59−$105.4K−6.5%119.5K after2 lots
Nov 2, 2023 (view filing)Nov 11 dayCrystal AdamSee RemarksSSale−7.51K$8.39−$63.0K−8.5%81.3K after